AU2001292320A1 - Benzylamine compound, process for producing the same, and intermediate therefor - Google Patents

Benzylamine compound, process for producing the same, and intermediate therefor

Info

Publication number
AU2001292320A1
AU2001292320A1 AU2001292320A AU9232001A AU2001292320A1 AU 2001292320 A1 AU2001292320 A1 AU 2001292320A1 AU 2001292320 A AU2001292320 A AU 2001292320A AU 9232001 A AU9232001 A AU 9232001A AU 2001292320 A1 AU2001292320 A1 AU 2001292320A1
Authority
AU
Australia
Prior art keywords
producing
same
benzylamine compound
intermediate therefor
therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001292320A
Inventor
Taketoshi Ishii
Hiroshi Mizuuchi
Akira Saito
Masakatsu Sugahara
Masami Takahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Publication of AU2001292320A1 publication Critical patent/AU2001292320A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
AU2001292320A 2000-10-02 2001-10-01 Benzylamine compound, process for producing the same, and intermediate therefor Abandoned AU2001292320A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000301563 2000-10-02
JP2000-301563 2000-10-02
PCT/JP2001/008616 WO2002028853A1 (en) 2000-10-02 2001-10-01 Benzylamine compound, process for producing the same, and intermediate therefor

Publications (1)

Publication Number Publication Date
AU2001292320A1 true AU2001292320A1 (en) 2002-04-15

Family

ID=18783085

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001292320A Abandoned AU2001292320A1 (en) 2000-10-02 2001-10-01 Benzylamine compound, process for producing the same, and intermediate therefor

Country Status (2)

Country Link
AU (1) AU2001292320A1 (en)
WO (1) WO2002028853A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0223077D0 (en) * 2002-10-04 2002-11-13 Univ Reading The Treatment of vascular diseases
KR20060079190A (en) 2003-08-14 2006-07-05 아사히 가세이 파마 가부시키가이샤 Substituted arylalkanoic acid derivative and use thereof
MXPA06003996A (en) * 2003-10-08 2006-07-05 Irm Llc Compounds and compositions as protein kinase inhibitors.
AU2011265521B8 (en) * 2005-07-15 2014-05-22 Merck Serono Sa JNK inhibitors for the treatment of endometreosis
US8546451B2 (en) 2005-11-28 2013-10-01 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
US9409856B2 (en) 2005-11-28 2016-08-09 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
US8637706B2 (en) 2005-11-28 2014-01-28 Gtx, Inc. Nuclear receptor binding agents
US8158828B2 (en) 2005-11-28 2012-04-17 Gtx, Inc. Nuclear receptor binding agents
EP2076513A1 (en) 2006-10-20 2009-07-08 Irm Llc Compositions and methods for modulating c-kit and pdgfr receptors
WO2008055842A1 (en) 2006-11-09 2008-05-15 F. Hoffmann-La Roche Ag Substituted 6-phenyl-pyrido [2,3-d] pyrimidin-7-one derivatives as kinase inhibitors and methods for using the same
US20100105688A1 (en) 2007-01-24 2010-04-29 Glaxo Group Limited Pharmaceutical compositions comprising 3,5-diamino-6-(2,3-dichlophenyl)-1,2,4-triazine or r(-)-2,4-diamino-5-(2,3-dichlorophenyl)-6-fluoromethyl pyrimidine and an nk1
EP3613743B1 (en) 2008-01-04 2022-03-16 Intellikine, LLC Processes for the preparation of 1h-pyrazolo[3,4-d]pyrimidin-4-amine derivatives
US8193182B2 (en) 2008-01-04 2012-06-05 Intellikine, Inc. Substituted isoquinolin-1(2H)-ones, and methods of use thereof
US9427418B2 (en) 2009-02-23 2016-08-30 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
US9624161B2 (en) 2009-02-23 2017-04-18 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
TWI674262B (en) 2011-01-10 2019-10-11 美商英菲尼提製藥股份有限公司 Processes for preparing isoquinolinones and solid forms of isoquinolinones
US8828998B2 (en) 2012-06-25 2014-09-09 Infinity Pharmaceuticals, Inc. Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
WO2015160975A2 (en) 2014-04-16 2015-10-22 Infinity Pharmaceuticals, Inc. Combination therapies
SG10201912456RA (en) 2016-06-24 2020-02-27 Infinity Pharmaceuticals Inc Combination therapies

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA41251C2 (en) * 1990-01-04 2001-09-17 Пфайзер, Інк. Hydrogenated nitrogen-containing heterocyclic substances, piperidine derivatives, pharmaceutical composition and method for inhibiting activity of p substance
JPH0794440B2 (en) * 1991-03-26 1995-10-11 フアイザー・インコーポレイテツド Stereoselective production of substituted piperidines
DK0655996T3 (en) * 1992-08-19 2001-12-27 Pfizer Substituted benzylamino nitrogen-containing, non-aromatic heterocyclic compounds
WO1994013663A1 (en) * 1992-12-10 1994-06-23 Pfizer Inc. Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists
IL111002A (en) * 1993-09-22 1998-09-24 Glaxo Group Ltd Piperidine derivatives their preparation and pharmaceutical compositions containing them
GB9513121D0 (en) * 1995-06-28 1995-08-30 Merck Sharp & Dohme Therapeutic agents
GB9525296D0 (en) * 1995-12-11 1996-02-07 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
WO2002028853A1 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
AU4467801A (en) Chlamydospores and process for producing the same
IL146105A (en) 5-pyridyl-1, 3-azole compounds, process for producing the same and use therefor
AU2002349477A1 (en) Bicyclic derivative, process for producing the same, and use
AU2856499A (en) Novel substances kf-1040t4a, kf-1040t4b, kf-1040t5a and kf-1040t5b and process for producing the same
AU6198700A (en) Process for producing phenyl-alkanes compositions produced therefrom, and uses thereof
AU2001292320A1 (en) Benzylamine compound, process for producing the same, and intermediate therefor
AU2001295611A1 (en) Multipressure method for producing ammonia
AU2001272757A1 (en) Process for producing 5-fluorooxyindole and for producing intermediate therefor
AU2001286188A1 (en) Tricyclic heterocyclic compound, process for producing the same, and use thereof
AU2002365372A1 (en) New process
AU2001242750A1 (en) Novel protein, process for producing the same and use thereof
AU5214300A (en) Method for producing 2,2,4,4-tetra-substituted 1,3,5-cyclohexanetriones
AU2001284442A1 (en) Process for producing fluoroalkanol
AU4692501A (en) Laminaribiose phosphorylase, process for producing the same and process for producing laminarioligosaccharide by using the enzyme
AU2001294181A1 (en) Novel protein, process for producing the same and use thereof
AU2001234795A1 (en) Process for obtaining 1, 2, 3, 5, 6, 7, 8, 8a-oltahydro-1, 2, 8, 8tetramethylnaphthalen-2-yl!etan-1-one
AU2002218479A1 (en) Novel beta-lactam compounds and process for producing the same
AU4951000A (en) Microliposomes and process for producing the same
AU2002216364A1 (en) Novel substance fki-1083 and process for producing the same
AU2000228300A1 (en) Novel substance fki-0076 and process for producing the same
AU2001227071A1 (en) Novel substance m-17a and process for producing the same
AU2000226913A1 (en) Novel antibiotic wk-6150 and process for producing the same
AU2002238832A1 (en) 2-methylindole-4-acetic acid, process for producing the same, and process for producing intermediate therefor
AU2001295925A1 (en) Process for producing diacetoxybutene
AU2002327363A1 (en) 11a-azalide compounds and process for producing the same